Company intelligence / Profile preview

Axon Vascular Europe

Altrincham, Cheshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

Axon Vascular Europe, as the European headquarters for Axon Therapies, is advancing a catheter-based, implant-free ablation procedure for heart failure, with ongoing double-blinded randomized feasibility trials in both HFpEF and HFrEF patient populations. Early clinical data are promising, supporting further pivotal studies.[1][2][3]

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Axon Vascular Europe.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Axon Vascular Europe.

Explore the full profile